Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Cash Management
1 Out of 3 Companies Increased Cash Holdings: Weekly Stat
Operating cash flows boosted many balance sheets in the 12 months ending March, but that will be harder to do this quarter.
By
Vincent Ryan
| July 6, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Generic Drugs
Credit & Capital
Akorn Files for Chapter 11 After Failed Takeover
The generic drugmaker listed $10 billion of debt and $10 billion of assets.
By
Lauren Muskett
| May 21, 2020
Read More
People
Cardinal Health CFO Leaves for Dentsply Job
Jorge Gomez's departure from Cardinal comes as the drug distributor struggles with generic drug price deflation.
By
Matthew Heller
| July 8, 2019
Read More
Financial Performance
Walgreens Slashes 2019 Outlook, Shares Dip 12%
The company's second-quarter report showed the continuing impact of shrinking generic drug sales on the country's largest pharmacy chains.
By
Matthew Heller
| April 2, 2019
Read More
Strategy
Shire Accepts Improved $62B Bid From Takeda
The deal is the largest-ever by a Japanese company and gives Takeda a lucrative portfolio of rare disease drugs.
By
Matthew Heller
| May 8, 2018
Read More
Strategy
Teva to Cut 14,000 Jobs in ‘Drastic’ Overhaul
The drugmaker says "there is no alternative" to its restructuring plan amid pricing pressure on its core generics business.
By
Matthew Heller
| December 14, 2017
Read More
Global Business
Teva Stock Drops 24% on Q2 Earnings Miss
The company's revenue rose 13% but the core generics business experienced "accelerated price erosion and decreased volume."
By
Matthew Heller
| August 4, 2017
Read More
Risk & Compliance
Mylan Underpaid U.S. on Rebates for EpiPen
A federal official says the drugmaker misclassified EpiPen, possibly costing Medicaid millions of dollars in rebates.
By
Matthew Heller
| October 6, 2016
Read More
Human Capital & Careers
Rite Aid Posts 22% Revenue Increase
But the drugstore chain's same store-sales fell short of estimates in part due to the introduction of low-margin generic drugs.
By
Matthew Heller
| December 17, 2015
Read More
Buzz
CFO Daily Roundup of July 27, 2015
A collection of CFO.com articles and stories published on July 27, 2015.
By
Kerry Maruna
| July 28, 2015
Read More
